Outcomes Associated with Clone-Directed Therapies for Monoclonal Gammopathy of Renal Significance

Peters, D. T., Amburn, J., Tuchman, S., Lichtman, E. I., Jensen, C. E., Jain, K., Lentzsch, S., Chakraborty, R., Bhutani, D., & Rubinstein, S. M. (2023). Outcomes Associated with Clone-Directed Therapies for Monoclonal Gammopathy of Renal Significance. Blood, 142(Supplement 1), 2027–2027. https://doi.org/10.1182/blood-2023-189341
Authors:
D. Peters
Jacob Amburn
Sascha A. Tuchman
Eben I. Lichtman
Christopher E. Jensen
Koyal Jain
Suzanne Lentzsch
Rajshekhar Chakraborty
Divaya Bhutani
Samuel M. Rubinstein
Affiliated Authors:
Suzanne Lentzsch
Rajshekhar Chakraborty
Divaya Bhutani
Publication Type:
Article
Unique ID:
10.1182/blood-2023-189341
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: